BAI-2 Antibodies

Santa Cruz Biotechnology delivers a wide array of BAI-2 monoclonal antibodies for research in understanding BAI-2's role in various biological processes. BAI-2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BAI-2, or Brain-specific Angiogenesis Inhibitor 2, is a member of the BAI family that plays a crucial role in regulating angiogenesis and neuronal development. BAI-2 influences cell signaling pathways and has been linked to various neurological disorders and cancer progression. Research has shown that BAI-2 expression patterns vary across different tissue types and developmental stages. Scientists have identified multiple domains within BAI-2 that contribute to its diverse biological functions. Recent studies have highlighted BAI-2's potential involvement in cell adhesion and migration. Understanding BAI-2's molecular mechanisms and interactions continues to be an active area of investigation. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of BAI-2's role in health and disease.